Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Profit After Tax (2013 - 2025)

Enlivex (ENLV) posted quarterly Profit After Tax of $1.2 billion for Q4 2025, up 24115.71% year-over-year from N/an in Q4 2024, and up 56474.29% quarter-over-quarter from -$2.2 million in Q3 2025.

Enlivex (ENLV) Profit After Tax (2013 - 2025) Analysis & Trends

Enlivex's Profit After Tax history runs 13 years deep, the most recent figure standing at $1.2 billion for Q4 2025.

  • In Q4 2025, Profit After Tax rose 24115.71% year-over-year to $1.2 billion; the TTM figure through Dec 2025 stood at $1.2 billion (up 14147.43% YoY), while the FY2025 annual figure was $1.2 billion, up 8329.17% from the prior year.
  • Profit After Tax for Q4 2025 stood at $1.2 billion, up from -$2.2 million in the prior quarter.
  • The five-year high for Profit After Tax was $1.2 billion in Q4 2025, with the low at -$9.9 million in Q2 2022.
  • The 5-year median for Profit After Tax is -$5.0 million (2021), against an average of $57.7 million.
  • The sharpest annual moves came in 2021 and 2025: Profit After Tax plunged 430.83% in 2021, then jumped 24115.71% in 2025.
  • Enlivex's Profit After Tax stood at -$4.7 million in 2021, then plunged by 51.79% to -$7.2 million in 2022, then slipped by 26.51% to -$9.1 million in 2023, then surged by 43.09% to -$5.2 million in 2024, then surged by 24115.71% to $1.2 billion in 2025.
  • Business Quant data shows ENLV's Profit After Tax at $1.2 billion in Q4 2025, -$2.2 million in Q3 2025, and $1.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Enlivex 4.51 Mn -1.25 Mn - -1.23 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.24 Bn
Sep 30, 2025 -2.21 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 -3.45 Mn
Dec 31, 2024 -5.18 Mn
Sep 30, 2024 -2.60 Mn
Jun 30, 2024 3.10 Mn
Mar 31, 2024 -4.14 Mn
Dec 31, 2023 -9.10 Mn
Sep 30, 2023 -5.96 Mn
Jun 30, 2023 -6.79 Mn
Mar 31, 2023 -7.22 Mn
Dec 31, 2022 -7.19 Mn
Sep 30, 2022 -5.73 Mn
Jun 30, 2022 -9.91 Mn
Mar 31, 2022 -8.23 Mn
Dec 31, 2021 -4.74 Mn
Sep 30, 2021 -3.42 Mn
Jun 30, 2021 -3.11 Mn
Mar 31, 2021 -5.99 Mn